M1137 Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care

Short descriptor: Docu dx degen neuro

⚠ Terminated HCPCS Level II 2026
Terminated Code
M1137 was terminated as of 2020-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open M1137 in the app →

Look up M1137 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

M1137 is the HCPCS Level II code for Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (2026). It belongs to Section M — Medical Services. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Not separately priced by Part B.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Not separately priced by Part B (indicator 00)
Type of Service
Medical care
Effective Date
2021-01-01
Termination Date
2020-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference M1137 with the canonical source and edition:

M1137 — Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/M1137

Canonical URL: https://icd10codingpro.com/hcpcs-codes/M1137

Related Codes in Section M

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial